Company
Avenzo Therapeutics
| Industry | clinical-stage biotechnology company developing new oncology therapies |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Avenzo Therapeutics | Series B | 2025-09-22 |
| Avenzo Therapeutics | Series A/A-1 | 2024-11-19 |
| Avenzo Therapeutics | Series A1- Financing | 2024-03-27 |